CBD advertising in France: what the law forbids you to say

The four laws aim at different things: packaging, health promises, consumer information and the product's image. One message can breach several of them at once, in which case the penalties add up.

Sold for smoking, a CBD flower belongs to the category of "herbal products for smoking other than tobacco", whose labelling comes under article L3514-3 of the Public Health Code. This article bans any element suggesting that the product is less harmful than another, or that it has "vitalising, energising, curative, rejuvenating, natural, organic" properties or benefits for health or lifestyle.

Sellers often miss three details of this article. It targets the words "natural" and "organic" in the same way as a promise of a cure. Packaging may not claim that a product is "additive-free", nor make it look like a food or a cosmetic. The ban also extends to "messages, symbols, names, product or service brands, figurative signs", so a brand name that suggests healing is covered just as a sentence would be.

These bans come with penalties. Article L3515-3 sets a €100,000 fine for using, on this packaging, a message, brand or sign banned by article L3514-3, and €200,000 for a repeat offence. The same article punishes selling a product whose packaging lacks the health warning. The wording of that warning is set by an order of 19 May 2016: "Fumer ce produit nuit à votre santé." ("Smoking this product harms your health."), over 30% of the front and 30% of the back.

These rules apply to packaging alone. A product page, a shop window or a social media post comes under the other three laws. What must appear on the label is detailed in our article on mandatory label information.

In the Public Health Code, what is said about a product counts as much as what it contains when deciding whether it is a medicine. According to article L5111-1, a medicine is "any substance or composition presented as having curative or preventive properties with regard to human diseases".

The seller's wording is therefore what triggers the rule. A seller who writes that an oil works against insomnia, anxiety or arthritis presents it as a medicine, and as one without the authorisation that status requires. Epidyolex, prescribed for rare forms of epilepsy, is the only CBD medicine authorised in France.

For products that are swallowed, the matter is now settled further upstream. On 20 May 2026, France's agriculture ministry restated that foods containing CBD are not authorised, supplements included, a change traced in our overview of CBD regulation in 2026. Creams and balms have their own limits under the cosmetics regulation, set out in our article on authorised cosmetic claims.

Misleading commercial practices are banned by the Consumer Code. Article L121-2 gives the list: a false or misleading claim about a product's composition, origin, conditions of use, "its properties and the results expected from its use", and about "the results and main features of tests and checks carried out".

CBD shops are directly concerned by that last point. A seller who states that a product is "tested batch by batch", or displays a level that differs from the batch sold, is as liable as one who makes a health promise. Every mention of lab testing needs a document that can be produced.

The penalties appear in article L132-2: two years in prison and a €300,000 fine. The fine can be raised to 10% of average annual turnover or to 50% of the advertising spend. If the offence is committed through an online public communication service, the penalties rise to five years and €750,000, which is the case for an online shop.

Article L3421-4 of the Public Health Code sets five years in prison and a €75,000 fine for any incitement to drug use, even when it has no effect. Presenting drug use in a favourable light is punished in the same way, as is inciting the use of substances "presented as having the effects" of narcotics. Near a school, the penalties rise to seven years and €100,000.

France's addiction monitoring centres applied this law to CBD marketing in a report funded by MILDECA, the government drug policy agency, and published on 1 December 2023. In the authors' view, terms borrowed from recreational cannabis, such as "space cake", "grinder" or "joint holder", amount to inciting drug use and may be prosecuted. Selling a product as "as strong as THC" may come under the second sentence of the article.

The report also examined 33 of the best-ranked online shops. Only a third of them stated that CBD is not a medicine, and half limited use to adults. Among the claims found were mentions of cardiovascular disease, psoriasis, seizures, cancer, multiple sclerosis or Parkinson's disease.

The only clear case is vaping. Article L3513-5 bans selling or giving a vaping product, with or without nicotine, to anyone under 18, and that includes a CBD e-liquid.

For smokable flowers, the French Senate adopted in May 2026 a government amendment extending this ban to herbal smoking products. As of 22 September 2026, the chapter of the code on these products still has no ban on sales to minors. A shop that refuses to sell to under-18s therefore does so by its own choice. Each format is reviewed in our article on the legal age for CBD.

The safest course is to describe what can be measured. Below are common phrases, the law each one breaches and a factual alternative.

A site has other obligations too: our list of information a CBD shop must display completes this checklist, and the steps are in our article on opening a CBD shop.